The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas

Efficacy and safety of rituximab treatment in patients with Hepatitis C virus (HCV) infection associated non-Hodgkin’s lymphoma (NHL) are still disputable. The aim of this study was to evaluate the influence of rituximab-containing chemotherapy on HCV load. Fifty-four patients with both HCV infectio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zhou, Xiang (VerfasserIn) , Kriegsmann, Katharina (VerfasserIn) , Giesen, Nicola (VerfasserIn) , Egerer, Gerlinde (VerfasserIn) , Ho, Anthony Dick (VerfasserIn) , Witzens-Harig, Mathias (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 July 2017
In: Annals of hematology
Year: 2017, Jahrgang: 96, Heft: 9, Pages: 1501-1507
ISSN:1432-0584
DOI:10.1007/s00277-017-3058-y
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00277-017-3058-y
Verlag, Volltext: https://link.springer.com/article/10.1007/s00277-017-3058-y
Volltext
Verfasserangaben:Xiang Zhou, Katharina Lisenko, Nicola Lehners, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig

MARC

LEADER 00000caa a2200000 c 4500
001 1578457718
003 DE-627
005 20230427065632.0
007 cr uuu---uuuuu
008 180810s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00277-017-3058-y  |2 doi 
035 |a (DE-627)1578457718 
035 |a (DE-576)508457718 
035 |a (DE-599)BSZ508457718 
035 |a (OCoLC)1341016677 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zhou, Xiang  |d 1990-  |e VerfasserIn  |0 (DE-588)1153553961  |0 (DE-627)1015048404  |0 (DE-576)500292566  |4 aut 
245 1 4 |a The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas  |c Xiang Zhou, Katharina Lisenko, Nicola Lehners, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig 
264 1 |c 1 July 2017 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.07.2020 
520 |a Efficacy and safety of rituximab treatment in patients with Hepatitis C virus (HCV) infection associated non-Hodgkin’s lymphoma (NHL) are still disputable. The aim of this study was to evaluate the influence of rituximab-containing chemotherapy on HCV load. Fifty-four patients with both HCV infection and NHL were identified between 2000 and 2016 at our institution. We retrospectively analyzed patients’ demographic characteristics, treatment, and kinetics of HCV load before and after treatment with rituximab-containing chemotherapy. In the total group of 54 patients, 29 (54%) received rituximab. Both HCV load pre rituximab and maximal HCV load post rituximab were available in 16 patients. Overall, we observed no significant difference between HCV load pre rituximab and the maximal HCV load post rituximab (P = 0.19). In a patient who was treated simultaneously with direct-acting antivirals (DAAs) and rituximab-containing chemotherapy, HCV load decreased below the sensitivity level (≤12 IU/ml) during treatment. When regarding the influence of rituximab-containing chemotherapy alone on HCV load, we observed a significant elevation of HCV load (P = 0.04). Rituximab-containing chemotherapy may lead to an increase of HCV load in patients with HCV-associated NHL. However, this finding is based on small patient cohort and should be confirmed in larger clinical trials. 
700 1 |a Kriegsmann, Katharina  |d 1986-  |e VerfasserIn  |0 (DE-588)1049422449  |0 (DE-627)781924006  |0 (DE-576)40339774X  |4 aut 
700 1 |a Giesen, Nicola  |d 1983-  |e VerfasserIn  |0 (DE-588)141844272  |0 (DE-627)631828524  |0 (DE-576)32643657X  |4 aut 
700 1 |a Egerer, Gerlinde  |e VerfasserIn  |0 (DE-588)105502168X  |0 (DE-627)792516745  |0 (DE-576)167430882  |4 aut 
700 1 |a Ho, Anthony Dick  |d 1948-  |e VerfasserIn  |0 (DE-588)108692477  |0 (DE-627)504904205  |0 (DE-576)19010466X  |4 aut 
700 1 |a Witzens-Harig, Mathias  |e VerfasserIn  |0 (DE-588)1050736516  |0 (DE-627)784812322  |0 (DE-576)404988970  |4 aut 
773 0 8 |i Enthalten in  |t Annals of hematology  |d Berlin : Springer, 1991  |g 96(2017), 9, Seite 1501-1507  |h Online-Ressource  |w (DE-627)253389852  |w (DE-600)1458429-3  |w (DE-576)072283157  |x 1432-0584  |7 nnas  |a The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas 
773 1 8 |g volume:96  |g year:2017  |g number:9  |g pages:1501-1507  |g extent:7  |a The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas 
856 4 0 |u http://dx.doi.org/10.1007/s00277-017-3058-y  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00277-017-3058-y  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180810 
993 |a Article 
994 |a 2017 
998 |g 1050736516  |a Witzens-Harig, Mathias  |m 1050736516:Witzens-Harig, Mathias  |d 910000  |d 910100  |e 910000PW1050736516  |e 910100PW1050736516  |k 0/910000/  |k 1/910000/910100/  |p 6  |y j 
998 |g 108692477  |a Ho, Anthony Dick  |m 108692477:Ho, Anthony Dick  |d 910000  |d 910100  |e 910000PH108692477  |e 910100PH108692477  |k 0/910000/  |k 1/910000/910100/  |p 5 
998 |g 105502168X  |a Egerer, Gerlinde  |m 105502168X:Egerer, Gerlinde  |d 910000  |d 910100  |e 910000PE105502168X  |e 910100PE105502168X  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 141844272  |a Giesen, Nicola  |m 141844272:Giesen, Nicola  |d 910000  |d 910100  |e 910000PG141844272  |e 910100PG141844272  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1049422449  |a Kriegsmann, Katharina  |m 1049422449:Kriegsmann, Katharina  |d 910000  |d 910100  |e 910000PK1049422449  |e 910100PK1049422449  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1153553961  |a Zhou, Xiang  |m 1153553961:Zhou, Xiang  |p 1  |x j 
999 |a KXP-PPN1578457718  |e 3020554799 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 10.07.2020"],"relHost":[{"origin":[{"publisher":"Springer","dateIssuedDisp":"1991-","dateIssuedKey":"1991","publisherPlace":"Berlin ; Heidelberg ; New York"}],"title":[{"title":"Annals of hematology","title_sort":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie"}],"id":{"eki":["253389852"],"issn":["1432-0584"],"zdb":["1458429-3"]},"part":{"issue":"9","extent":"7","pages":"1501-1507","year":"2017","volume":"96","text":"96(2017), 9, Seite 1501-1507"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"disp":"The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomasAnnals of hematology","recId":"253389852","titleAlt":[{"title":"Hematology"}],"language":["eng"],"pubHistory":["62, 1 (Februrary 1991)-"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"physDesc":[{"extent":"7 S."}],"id":{"eki":["1578457718"],"doi":["10.1007/s00277-017-3058-y"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"The influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas","title_sort":"influence of rituximab-containing chemotherapy on HCV load in patients with HCV-associated non-Hodgkin’s lymphomas"}],"language":["eng"],"person":[{"role":"aut","given":"Xiang","display":"Zhou, Xiang","family":"Zhou"},{"family":"Kriegsmann","display":"Kriegsmann, Katharina","given":"Katharina","role":"aut"},{"family":"Giesen","display":"Giesen, Nicola","given":"Nicola","role":"aut"},{"display":"Egerer, Gerlinde","given":"Gerlinde","family":"Egerer","role":"aut"},{"given":"Anthony Dick","display":"Ho, Anthony Dick","family":"Ho","role":"aut"},{"family":"Witzens-Harig","given":"Mathias","display":"Witzens-Harig, Mathias","role":"aut"}],"name":{"displayForm":["Xiang Zhou, Katharina Lisenko, Nicola Lehners, Gerlinde Egerer, Anthony D. Ho, Mathias Witzens-Harig"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"1 July 2017"}],"recId":"1578457718"} 
SRT |a ZHOUXIANGKINFLUENCEO1201